MPC1 and colorectal cancer: Increased levels of pyruvate in JIMT1 cells due to GYY4137 treatment might be attributed to the reduction in mitochondrial import of pyruvate due to low expression of mitochondrial pyruvate carrier 1, as it was described in colorectal cancer cells [39].